The global vascular stents market was valued at US$ 8.8 Billion in 2019. A vascular stent is a small device that is used to clear and prevent blockages in the heart valves and arteries. It is also used to provide internal structural support to stenotic or occluded blood vessels. The process of placing a vascular stent inside the body is known as vascular stenting. Vascular stents are usually made of polyethylene, polypropylene or non-absorbable materials such as stainless steel or cobalt-chromium alloys. They may vary from tubular stent-grafts, which are used to repair aneurysms, to expandable metal meshes that are used during percutaneous vessel interventions. Once the stent is placed in the intended location, it is expanded using a balloon or a self-expanding mechanism.
Rapidly increasing geriatric population is one of the major factors driving the market growth worldwide. Furthermore, there has been a rise in the incidence rate of various ailments such as peripheral artery disease (PAD), aortic aneurysm, and ischemic heart disease. The frequent occurrence of these ailments has led to a growing requirement for vascular stents. This can be attributed to lifestyle choices such as smoking and high alcohol consumption coupled with physical inactivity and unhealthy dietary habits of individuals. Additionally, increasing consumer inclination toward minimally invasive (MI) procedures is also driving the market growth. The MI vascular stenting procedures ensure shorter hospital stay, quick recovery and greater comfort for the patients. Moreover, the emerging trend of peripheral and endovascular aneurysm repair (EVAR) stent grafting is also contributing to the market growth. The EVAR is widely preferred for patients with advanced age and renal dysfunction, while peripheral stenting is done to provide support to femoropopliteal and infrapopliteal arteries above the knee. Looking forward, IMARC Group expects the global vascular stents market to exhibit moderate growth during the next five years.
The report has also analysed the competitive landscape of the market with some of the key players being Medtronic Plc, Abbott Laboratories, Boston Scientific Corporation, Biotronik Se & Co. Kg, Braun Melsungen Ag, Terumo Corporation, Microport Scientific Corporation, Meril Life Sciences Pvt. Ltd., Vascular Concepts Limited, C.R. Bard, Inc., W.L. Gore and Associates, Inc., Endologix, Inc., Lombard Medical, Translumina Gmbh, Jotec Gmbh, etc.
Key Questions Answered in This Report:
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-702-409-7331 )
( India: +91-120-433-0800 )
Drop us an email at